Post operative pain management

Comparitive study of levobupivacaine vs levobupivacaine with dexmedetomidine as an adjuvant in transversus abdominis block for post operative pain relief in total abdominal hysterectomy patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041932

Enrollment

Registered

2022-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: TAP block: Tap block using 20ml 0.25%Levobupivacaine with 2 ml NS bilaterally Control Intervention1: TAP block: 20 ml of 0.25% levobupivacaine with 0.5 mcg/kg dexmedetomidine bilaterall

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for toal abdominal hysterectomy having ASA grade 1 and 2

Exclusion criteria

Exclusion criteria: Not willing to participate, ASA grade 3 or more,allergic to drug used,

Design outcomes

Secondary

Measure	Time frame
To study changes in serum cortisol levels( pre and post op) after giving TAP blockTimepoint: Preop cortisol-1 day before Postop cortisol- after 12 hrs of surgical incision	—

Primary

Measure	Time frame
To study the analgesic effect of dexmedetomidine (0.5mcg/kg) added to 20 ml of 0.25% levobupivacaine on each side in TAP block in patients undergoing total abdominal hysterectomyTimepoint: At 2 hrs,4 hrs,6hrs,8hrs,12hrs and 24hrs	—

Countries

India

Contacts

Public ContactDr Wasimul Hoda

RIMS

singhromin37@gmail.com7903882476

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026